GlobeNewsWire
26 Mar 2026, 16:45 UTC · 29w ago
Verdict
Headline takes no side. We score VALN +0.60 — strongly bullish.
+0.60strongly bullish
More positive than 79% of ticker scores this week
Which stocks this story touches
More positive than 79% of ticker scores this week
The company is actively promoting its chikungunya vaccine progress and participating in a major industry congress to engage potential partners.
More positive than 51% of ticker scores this week
Mentioned as a partner in the development of a Lyme disease vaccine candidate.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 74% of relationship scores this week
[mutual] Valneva is partnered with Pfizer on a Lyme disease vaccine candidate in advanced clinical development.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
1d ago
−14.2%
Price is moving against the score
$5.56 vs $6.48 close before publication (Mar 25) · not market-adjusted
VALN chart →
